| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Obesity: Original Article |
Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, 6200 MD Maastricht, The Netherlands
Address all correspondence and requests for reprints to: G. H. Goossens, Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. E-mail: g.goossens{at}hb.unimaas.nl.
The present study was designed to investigate the effects of angiotensin II (Ang II) on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects using the microdialysis technique. Microdialysis probes were placed in the abdominal sc adipose tissue left and right from the umbilicus and in the gastrocnemius muscle of both legs in eight normal-weight and eight obese men. Probes were consecutively perfused with 1.0 nM Ang II, 1.0 µM Ang II, and 1.0 µM Ang II + 48 µM hydralazine or with Ringer solution (control). Ethanol and glycerol concentrations in the dialysate were measured as an indicator of local blood flow and lipolysis, respectively. Ang II caused an increase in ethanol outflow/inflow ratio, compared with baseline values both in adipose tissue (average of both groups, Ang 1.0 nM: 0.03 ± 0.01, P = 0.02; Ang 1.0 µM: 0.05 ± 0.01, P < 0.01) and muscle (average of both groups, Ang 1.0 nM: 0.02 ± 0.01, P = 0.09; Ang 1.0 µM: 0.04 ± 0.01, P = 0.01), indicating a decrease in local blood flow. These effects were not significantly different in obese and normal-weight subjects. The decrease in local blood flow was accompanied by unchanged interstitial glycerol concentrations in adipose tissue (except during the supraphysiological dose) and skeletal muscle, suggesting that Ang II inhibits lipolysis in both tissues. Thus, the present data suggest that Ang II decreases local blood flow in a dose-dependent manner and inhibits lipolysis both in adipose and skeletal muscle tissue. These effects were not significantly different in obese and normal-weight subjects in both tissues.
Abbreviations: Ang II, Angiotensin II; ANP, atrial natriuretic peptide; RAS, renin-angiotensin system.
This article has been cited by other articles:
![]() |
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rao, Z. H. Huang, and T. Mazzone Angiotensin II Regulates Adipocyte Apolipoprotein E Expression J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4366 - 4372. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Goossens, J. W.E. Jocken, E. E. Blaak, P. M. Schiffers, W. H.M. Saris, and M. A. van Baak Endocrine Role of the Renin-Angiotensin System in Human Adipose Tissue and Muscle: Effect of {beta}-Adrenergic Stimulation Hypertension, March 1, 2007; 49(3): 542 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Goossens, S. E. McQuaid, A. L. Dennis, M. A. van Baak, E. E. Blaak, K. N. Frayn, W. H. M. Saris, and F. Karpe Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans J. Physiol., March 1, 2006; 571(2): 451 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boschmann, S. Engeli, F. Adams, G. Franke, F. C. Luft, A. M. Sharma, and J. Jordan Influences of AT1 receptor blockade on tissue metabolism in obese men Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R219 - R223. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Robertson, A. S. T. Bickerton, A. L. Dennis, H. Vidal, D. P. Jewell, and K. N. Frayn Enhanced Metabolic Cycling in Subjects after Colonic Resection for Ulcerative Colitis J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2747 - 2754. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cabassi, P. Coghi, P. Govoni, E. Barouhiel, E. Speroni, S. Cavazzini, A. M. Cantoni, R. Scandroglio, and E. Fiaccadori Sympathetic Modulation by Carvedilol and Losartan Reduces Angiotensin II-Mediated Lipolysis in Subcutaneous and Visceral Fat J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2888 - 2897. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |